ORIGIN researcher Dr Orla Houlihan highlighted the role for personalised brachytherapy treatment in cervical cancer at the Annual Scientific Meeting of the British Gynaecological Cancer Society in London. Dr Houlihan’s recent review emphasises the clinical need for in vivo dosimetry to monitor radiation dose and radioactive source location in real-time.
Add a Comment
You must be logged in to post a comment